Pharmaceuticals & Chemicals

Pharmaceutical Research and Development (R&D) works to discover, developing, and bringing new drugs and therapies to market.

Chemical R & D focused on creating new substances or improving existing ones for a wide range of application by other industries (e.g., plastics, agrochemicals, specialty chemicals, paints, electronics).

AVA Healthcare keen to play a pivotal role in advancing national & global healthcare by addressing unmet medical & industrial needs, improving treatment efficacy, and ensuring drug safety.

Key Aspects of Pharmaceutical R&D at AVA Healthcare includes:

1. Preclinical Research

2. Clinical Trials: – Conducted in three phases (I-III) to evaluate safety, dosage, and effectiveness in humans. Phase IV (post-marketing surveillance) monitors long-term effects after approval.

3. Post-Market Studies

4. Personalized Medicine: Tailoring treatments based on genetics and biomarkers.

5. Biologics & Biosimilars: Growing focus on monoclonal antibodies, cell & gene therapies.

6. Collaborative R&D: Partnerships between different pharma companies, biotech firms, and academia to share risks and expertise.

The R&D at AVA Healthcare is a dynamic and innovation-driven place essential for industrial & medical progress. AVA Healthcare is committed to continues works and collaboration with different organisations to addressing the challenges and delivering advanced solutions.